Melanin Binding Agents for Targeted Topical Delivery

US2016235642A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016235642-A1
Application numberUS-201414379795-A
CountryUS
Kind codeA1
Filing dateMar 11, 2014
Priority dateMar 15, 2013
Publication dateAug 18, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions and methods are disclosed for targeted delivery of a benefit agent to areas of a human integument having melanin deposits. The compositions comprise a pyridinium compound having affinity for melanin. The compounds may be bound to a benefit agent, such as a pigment and may be topically applied to a human integument.

First claim

Opening claim text (preview).

1 .- 41 . (canceled) 42 . A method for targeted delivery of a benefit agent to areas of human integument having melanin deposits, comprising topically applying to said integument a composition comprising the reaction product of a benefit agent and compound capable of binding to melanin having the structure of Formula (I): wherein, L is a divalent C 4-32 hydrocarbon moiety, optionally substituted with heteroatoms selected from Si, O, S, N, and halogen, and optionally substituted with one or more groups R; and is a functional group capable of forming a bond with said benefit agent; for conjugating said compound to a benefit agent, and R 1 -R 5 are independently selected, at each occurrence, from a group R; wherein R is selected from hydrogen, —F; —Cl; —Br; —I; —OH, —OR*; —NH 2 ; —NHR*; —N(R*) 2 ; —N(R*) 3 + ; —N(R*)—OH; —N(→O)(R*) 2 ; —O—N(R*) 2 ; —N(R*)—O—R*; —N(R*)—N(R*) 2 ; —C═N—R*; —N═C(R*) 2 ; —C═N—N(R*) 2 ; —C(═NR*)—N(R*) 2 ; —SH; —SR*; —C≡N, —NC; —(C═O)—R*; —CHO; —CO 2 H; —CO 2 − ; —CO 2 R*; —C(═O)Cl, —(C═O)—S—R*; —O—(C═O)—H; —O—(C═O)—R*; —S—(C═O)—R*; —(C═O)—NH 2 ; —(C═O)—N(R*) 2 ; —(C═O)—NHNH 2 ; —O—(C═O)—NHNH 2 ; —(C═S)—NH 2 ; —(C═S)—N(R*) 2 ; —N(R*)—CHO; —N(R*)—(C═O)—R*; —(C═NR)—O—R*; —O—(C═NR*)—R*, —SCN; —NCS; —NSO; —SSR*; —N(R*)—C(═O)—N(R*) 2 ; —N(R*)—C(═S)—N(R*) 2 ; —SO 2 —R*; —O—S(═O) 2 —R*; —S(═O) 2 —OR*; —N(R*)—SO 2 —R*; —SO 2 —N(R*) 2 ; —O—SO 3 − ; —O—S(═O) 2 —OR*; —O—S(═O)—OR*; —O—S(═O)—R*; —S(═O)—OR*; —S(═O)—R*; —NO; —NO 2 ; —NO 3 ; —O—NO; —O—NO 2 ; —N 3 ; —N 2 —R*; —N(C 2 H 4 ); —Si(R*) 3 ; —CF 3 ; —O—CF 3 ; —PR* 2 ; —O—P(═O)(OR*) 2 ; —P(═O)(OR*) 2 ; —CH 3 , —CR*═CR* 2 , —C≡CH, —Si(OR*) 3 , —Si(R*) 2 H, C 1 -C 12 perfluoroalkyl; an aliphatic C 1 -C 12 hydrocarbon radical; a C 1 -C 12 aromatic hydrocarbon radical; or a C 1 -C 12 heteroaryl radical; R* is independently at each occurrence hydrogen or a straight chained, branched, or cyclic C 1 -C 20 hydrocarbon radical, which may be saturated, partially saturated, or aromatic, each of which may be optionally substituted with 1-6 heteroatoms selected from nitrogen, oxygen, sulfur, or halogen, and wherein any two adjacent R* groups may together form a 3-8 membered aromatic, partially unsaturated, or saturated ring. and topically acceptable salts thereof. 43 . The method according to claim 42 , wherein L is further characterized as having an octanol-water partition coefficient, expressed as Log(K ow ), of the corresponding alcohol HO-L-CH 3 between 1 and about 10. 44 . The method according to claim 42 , wherein L is a C 4-32 alkyl or alkenyl group. 45 . The method according to claim 44 , wherein L is a straight chained C 6-16 alkyl or alkenyl group. 46 . The method according to claim 42 , wherein L is a divalent C 4-32 hydrocarbon moiety of the form —X 1 —(CR* 2 ) n —X 2 —(CR* 2 ) m —X 3 —, where X 1 is selected from the group consisting of a bond, —CH 2 —, —CR* 2 —, —CR*═CR*—, —C≡C—, —(C═O)—, —(C═O)—O—, —(C═O)—NR*—, —Si(R*) 2 —, —(CR* 2 ) i —Si(R*) 2 —, —(CR* 2 ) i —(Si(R*) 2 ) j —(O—Si(R*) 2 ) k — (where “i” is an integer from 0-10, “j” is zero or one and “k” is an integer from 1-10); and X 2 , and X 3 are independently at each occurrence a bond, —O—, —NR*—, —S—, —CH 2 —, —CR* 2 —, —CR*═CR*—, —C≡C—, —(C═O)—, —(C═O)—O—, —(C═O)—NR*—, —(OCH 2 CH 2 ) y —, or —(CH 2 CH 2 O) z — (wherein “y” and “z” are independently an integer from 1 to 12), —Si(R*) 2 —, —(Si(R*) 2 ) j —(O—Si(R*) 2 ) k — (where “j” is zero or one and “k” is an integer from 1-10), and “n” and “m” are independently an integer from 0 to 30 47 . The method according to claim 46 , wherein “n” and “m” are independently integers from 6 to 24, with the proviso that at least one of “m” and “n” is not zero. 48 . The method according to claim 46 , wherein L has the form —(CH 3 ) z — (where “z” is an integer from 6-18), —R a —O—R b —, —R a —S—R b —, —R a —Si(CH 3 ) 2 —R b —, —R a —Si(CH 3 ) 2 —O—Si(CH 3 ) 2 —R b —, or —R a —Si(CH 3 ) 2 —(O—Si(CH 3 ) 2 ) k —R b —, where R a and R b are independently C 1-12 straight chain alkyl groups, and “k” is an integer from 1-12. 49 . The method according to claim 42 , wherein R 1 , R 2 , R 4 , and R 5 are hydrogen. 50 . The method according to claim 42 , wherein Ω is selected from chloro, bromo, iodo, mesyl, tosyl, —OH, —SH, —NH 2 ; —NHR*, —(C—NR* 2 )═R*, —CR*═CR* 2 , —C≡CH, —CR*(O)CR* (epoxide), —Si(OR*) 3 , —Si(R*) 2 H, —(Si(R*) 2 ) j —(O—Si(R*) 2 ) k —Si(OR*) 3 , —(Si(R*) 2 ) j —(O—Si(R*) 2 ) k —Si(R*) 2 H, —CO 2 H; —CO 2 R*; —C(═O)Cl, —CH 2 O(C═O)CH 2 (C═O)CH 3 , —C(O)—O—(N(—(C═O)—R*) 2 ), —SO 2 Cl, —NCS, —NCO, —N 3 , —N 2 + Cl; or a group R. 51 . The method according to claim 42 , wherein Ω is a trialkoxysilane of the form —Si(OR*) 3 where R* is independently selected at each occurence from C 1-6 hydrocarbons. 52 . The reaction product of an inorganic oxide particle and a compound of Formula (I): where L has the form —(CH 3 ) z —, where “z” is an integer from 6-18; Ω is a trialkoxysilane of the form —Si(OR*) 3 , where R* is independently selected at each occurence from C 1-6 hydrocarbons; and R 1 , R 2 , R 4 , and R 5 are hydrogen, R 3 is hydrogen, —CH 3 , —OCH 3 , —OH, —SH, or —NH 2 . 53 . The method according to claim 52 , wherein said inorganic oxide is selected from the group consisting of iron oxides, titanium dioxide, zinc oxide, alumina, and silica. 54 . A surface-functionalized pigment, wherein said pigment has covalently attached to the surface thereof, a plurality lipophilic pyridinium compounds. 55 . A compound of Formula (II):

Assignees

Inventors

Classifications

  • for chemically bleaching or whitening the skin · CPC title

  • Titanium compounds · CPC title

  • Heavy metals; Compounds thereof · CPC title

  • Oxides of iron · CPC title

  • Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016235642A1 cover?
Compositions and methods are disclosed for targeted delivery of a benefit agent to areas of a human integument having melanin deposits. The compositions comprise a pyridinium compound having affinity for melanin. The compounds may be bound to a benefit agent, such as a pigment and may be topically applied to a human integument.
Who is the assignee on this patent?
Avon Prod Inc
What technology area does this patent fall under?
Primary CPC classification A61K8/585. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Aug 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).